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Internal defibrillation is commonly indicated for shockable rhythm 
following cross-clamp removal in cardiac surgery. Low energy decreases 
the success rate of defibrillation but high energy can cause myocardial 
damage. This study aimed to determine the success rate of internal 
defibrillation for shockable arrhythmias after cardiac surgery.
Retrospective data of 1,424 patients who developed shockable rhythms 
(ventricular fibrillation or ventricular tachycardia), and required internal 
defibrillation after aortic cross-clamp removal during cardiac surgery, 
without deep hypothermic circulatory arrest technique, from August 2015 
to July 2017, were reviewed.
The overall success rate of internal defibrillation in the first attempt of 
defibrillation was 61.5%. The success rate of the energy levels at 30, 10, 
and 7 Jules were 66.7, 64.9, and 61.5%, respectively. The success rate was 
higher in patients who had a better ejection fraction than those who failed 
after defibrillation. This was significantly associated with higher pH, higher 
bicarbonate, lower serum calcium, and lower total cardioplegic volume 
during cardiopulmonary bypass (CPB). Redo-valve surgery, valvular 
surgery, and combined coronary artery bypass graft with valvular surgery 
had a non-significantly lower success rate (p-value = 0.989). Incidence of 
failure for defibrillate patients in redo-valvular surgery, combined coronary 
artery bypass graft with valve surgery, adult congenital heart defect, and 
valvular surgery; requiring four or five shocks was non-significantly 
increased. Recurrent rate of ventricular fibrillation/ventricular tachycardia 
was 13.5%.
The success rate of internal defibrillation was not related to the dose of 







During cardiac surgery, most patients require the 
cardiopulmonary bypass (CPB) system. For discontinuing 
CPB, at the end of the surgery, one of the important factors 
for weaning from CPB is cardiac rhythm. An organized, 
effective, and stable cardiac rhythm can occur spontaneously 
after removal of the aortic cross-clamp; however, in some 
cases cardiac conduction may resume electrical activity with 
ventricular fibrillation (VF) and/or ventricular tachycardia 
(VT). If VF occurs in a warm myocardium, it can increase 
cardiac wall tension, compromising endocardial perfusion, 
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and allowing for possible subendocardial infarction. 
Defibrillation is only indicated for shockable rhythms 
(VF, VT). Energy levels of internal defibrillation can start 
at 5-10 Jules [1-3], and may be increased up to 50 Jules in 
some patients. Defibrillation is more effective when the 
heart is adequately rewarmed to a general body temperature 
(more than 30 degrees Celsius), with the success rate at 
approximately 56-64% [2]. If ventricular fibrillation persists 
or recurs repeatedly after multiple, unsuccessful attempts 
of defibrillation, further management is to further warm the 
heart; so as to correct electrolyte abnormalities, and to begin 
antiarrhythmic drugs. Although, defibrillation is a life-saving 
procedure, the delivery of multiple high-energy shocks 
may be associated with myocardial damage and subsequent 
hemodynamic impairment [4]. Additionally, large shocks can 
damage cells and result in post-shock arrhythmias that may 
reinitiate fibrillation [1,4].
The primary objective of this study was to determine 
the success rates of different energy levels of internal 
defibrillation for VF or VT after CPB. The secondary 
objective was to determine the factors affecting the 
success of internal defibrillation.
2. Material and Methods
2.1 Study Design
This study was approved by the Local Research and Ethics 
Committee of the Faculty of Medicine, Prince of Songkla 
University (REC. 60-360-08-1). By reviewing the retrospective 
data from the medical records, anesthetic records, and CPB 
records of cardiac surgical patients in Songklanagarind Hospital, 
from; February 2014 to July 2017.
2.2 Participants
All patients who developed VF or VT during weaning 
from CPB, with a body temperature above 30°C were 
included in the study (Figure 1). The exclusion criteria 
were patients aged under 18-year-old and/or used the deep 
hypothermic circulatory arrest (DHCA) technique during 
surgery. The selection of each energy level and types of 
antiarrhythmic agents for defibrillation were determined 
by the decision of the attendant anesthesiologist. Repeated 
attempts of defibrillations were needed for unsuccessful 
conversions, or for recurrent episodes of shockable rhythms. 
2.3 Measures 
Patient demographic data included: age, gender, body 
mass index (BMI), comorbidities, current medications, 
preoperative ejection fraction (EF), preoperative congestive 
heart failure, left ventricular hypertrophy, American 
Society of Anesthesiologists (ASA) classification, and type 
of surgery. The intraoperative cardiopulmonary bypass 
data included: the success rate and level of energy for 
defibrillation, and the number of internal defibrillations. The 
factors affecting the success of internal defibrillation; such as, 
arterial blood gas, electrolytes, body temperature, CPB and 
aortic cross-clamp time, use of inotropic/vasopressor agents, 
antiarrhythmic agents, type of operations and recurrent VF/
VT, were recorded.
2.4 Sample Size
After reviewing the using of 7 Jules of energy level of 
internal defibrillation in patients who developed VT/VF 
during cardiac surgery in Songklanagarind Hospital, the 
success rate approximately was 60%. It was then used for 
the sample size calculation with the accepted maximum 
error of 0.1, and significant level of 0.05. To cover the 
10% dropout rate, the sample size finally was 104 patients.
2.5 Analysis
Statistical analysis was performed using the R program 
(version 3.14). Patient characteristics are described as the 
mean, and standard deviation for the normal distribution, 
as the median and interquartile range (IQR) for the non-
normal distribution, or absolute and relative frequencies. 
The comparisons between the groups were performed with 
the unpaired t-test for normally distributed data, or with 
the Mann-Whitney U test for other quantitative data; and 
with the Chi-squared test or Fisher exact test for qualitative 
variables. Univariate regression and multivariate analysis 
were performed to assess the association between the success 
of energy level and the perioperative variables. Statistical 
significance was considered if p-value < 0.05.
3. Results
Among a total of 1,424 patients undergoing cardiac 
DOI: https://doi.org/10.30564/jim.v10i2.3459
Figure 1. Flow diagram of the study
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surgery without DHCA technique, a hundred and four 
patients (7.3%) had VF/VT during weaning from CPB. 
The majority of patients were men (68.3%), with the mean 
age ± S.D. being 53.5 ±14.1 years old (range between 
18-82 years of age); common current medications before 
surgery were diuretics (69.2%). The cardiac operations 
were mainly elective surgery (83.7%), and valvular heart 
surgery (61.5%). The types of surgeries were similar 
between the two groups. Baseline cardiac rhythm before 
surgery was normal sinus rhythm (67.3%), while pre-
operative ejection fraction was 53.4 ±15%. Most patients 
(74%) had left ventricular hypertrophy (LVH); 34.6% 
of patients had a diagnosis of congestive heart failure 
and 16.3% patients received inotropic agents before 
surgery (Table 1). The pre-operative ejection fraction in 
patients who were successfully converted after shock 
(56.9 ±13.1%) was higher than those who failed after 
defibrillation (48.1 ±16.2%), p-value = 0.011).
From a total of 104 patients who had VF/VT, 64 patients 
(61.5%) were shocked successfully, while 40 patients (38.5%) 
were failed after the first attempt of defibrillation. The energy 
used for the first attempt of internal defibrillation started 
at 5, 7, 10, 20, and 30 Jules (J). Most of the energy levels 
were 10 J (57.8%), following by 20 J(23.4%), 10 J(12.5%), 
5 J(3.1%) then 30 J(3.1%). The success rates of the first 
attempt defibrillation at 30, 10, and 7 J were 66.7, 64.9, and 
61.6%, respectively (Table 2). The use of energy levels at 5 
and 20 J had lower success rates (50.0 and 55.6%). With sub-









Age, median ±IQR 53.5 ±14.1* 58 (47.8,65.0) 54 (37.5,59.2) 0.07
Gender, n (%) 1.00
   male 71 (68.3) 44 (68.8) 27 (67.5)
   female 33 (31.7) 20 (31.2) 13 (32.5)
BMI, median ±IQR 22.7 ± 4.1* 22.9 (19.8,24.9) 22.9 (20.6,25.4) 0.51
Comorbid disease, n (%) 33 (31.7) 22 (34.4) 11 (27.5) 0.61
   diabetes 12 (11.5) 6 (9.4) 6 (15.0) 0.53
   hypertension 30 (28.8) 20 (31.2) 10 (25.0) 0.64
   dyslipidemia 10 (9.6) 7 (10.9) 3 (7.5) 0.74
Current medication, n (%) 93 (89.4) 58 (90.6) 35 (87.5) 0.74
ASA physical status, n (%) 0.46
   3 82 (78.8) 53 (82.8) 29 (72.5)
   4 18 (17.3) 9 (14.1) 9 (22.5)
   5 4 (3.8) 2 (3.1) 2 (5.0)
Type of surgery, n (%) 0.60
   Elective 87 (83.7) 55 (85.9) 32 (80.0)
   Emergency 17 (16.3) 9 (14.1) 8 (20.0)
Preoperative EF, mean ±SD 53.4 ±15 56.9 ± 13.1 48.1 ± 16.2 0.01
ECG baseline, n (%) 0.30
   Normal sinus 70 (67.3) 39 (60.9) 31 (77.5)
   Atrial fibrillation 27 (26.0) 20 (31.2) 7 (17.5)
   Heart block 1 (1.0) 1 (1.6) 0 (0)
   Bradycardia 6 (5.8) 4 (6.2) 2 (5.0)
Left ventricular hypertrophy 77 (74.0) 44 (68.8) 33 (82.5) 0.18
Preoperative congestive heart failure, n (%) 36 (34.6) 18 (28.1) 18 (45) 0.12
Preoperative use inotropic drug, n (%) 17 (16.3) 9 (14.1) 8 (20.0) 0.60
   Norepinephrine 2 (1.9) 0 (0) 2 (5.0) 0.15
   Dopamine 11 (10.6) 5 (7.8) 6 (15.0) 0.33
   Dobutamine 5 (4.8) 4 (6.2) 1 (2.5) 0.65
Operations, n (%) 0.99
   Coronary bypass graft (CABG) 11 (10.6) 7 (63.6) 4 (36.4)
   Adult congenital heart diseases 3 (2.9) 2 (66.7) 1 (33.3)
   Valvular heart surgery 64 (61.5) 39 (60.9) 25 (39.1)
   Combined CABG+ valve surgery 9 (8.7) 5 (55.6) 4 (44.4)
   Redo-valvular surgery 4 (3.8) 2 (50.0) 2 (50.0)
   Thoracic aorta surgery without DHCA 8 (7.7) 5 (62.5) 3 (37.5)
   Other (pulmonary embolectomy, myxoma removal) 5 (4.8) 4 (80.0) 1 (20.0)
*= mean ± S.D., ASA = American Society of Anesthesiologists, BMI = body mass index, DHCA = deep hypothermic circulatory 
arrest, ECG = electrocardiography, EF = ejection fraction, VF = ventricular fibrillation, VT = ventricular tachycardia
DOI: https://doi.org/10.30564/jim.v10i2.3459
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analysis from a total of 27 defibrillations of the energy level 
at 20 J, these occurred mainly in valvular surgery (59.3%). 
Failure of shock was largely found in coronary artery bypass 
graft (CABG) and combined CABG with valvular surgery 
(66.7%). However, the success rates were not significantly 
different in the first attempt of defibrillation among each 
energy level (5, 7, 10, 20, and 30 J) (p-value = 0.9). 
After the first attempt of defibrillation, forty patients 
(38.5%) had failure to convert VF/VT into a normal sinus 
rhythm. These patients required a second defibrillation, with 
55% having successful shocks; eighteen patients required 
a third attempt, with 50% of successful defibrillation. 
Additionally, nine patients required a fourth attempt, with 
44.4% having successful defibrillation. Five patients required 
a fifth attempt, with 100% having successful defibrillation 
at the energy levels of 20, 30 and 50 Jules (Table 2). The 
energy levels in the second, third, and fourth attempt were 
significantly increased at higher levels than those in the 
earlier attempt (p-value < 0.001). The energy levels of the 
success in the third and the fourth attempts were higher than 
those in the failure of defibrillation; nevertheless, they were 
not significantly different (p-value 0.51), (Figure 2).
Thirteen patients (0.9%) had recurrent or a second episode 
of VF/VT, after successful normal rhythm conversion. From 
the first to the third attempt of defibrillation, for the second 
episode of VF/VT, the energy levels in the failed attempt 
were higher than those in successful defibrillation; however, 
they were not significantly different (Figure 3). The recurrent 
rates of shockable rhythms were 27.3, 25, 14.1, and 12.5 
%; in the CABG, redo-valve, valvular surgery, and thoracic 
aortic surgeries, respectively. CABG and redo-valvular 
surgery had recurrent rates more than other surgeries. Third 
recurrent episodes of VT/VF occurred in six patients (0.4%). 
All of these required only one attempt of defibrillation at 
the energy levels of 5, 20, 30, and 50 Jules to successfully 
convert their rhythms (Table 2).
Table 2. The level of energy, success, and the attempts of internal defibrillation for the first and recurrent shockable 
rhythms
VT/VF








Yes 2(50.0) 8(61.5) 37(64.9) 15(55.6) 2(66.7) 0
no 2(50.0) 5(38.5) 20(35.1) 12(44.4) 1(33.3) 0
second
yes 0 0 7(70.0) 11(55.0) 4(50.0) 0
no 0 2(100) 3(30.0) 9(45.0) 4(50.0) 0
third
yes 0 0 2(66.7) 1(16.7) 6(75.0) 1(100)
no 0 0 1(33.3) 5(83.3) 2(25.0) 0
fourth
yes 0 0 0 0 3(50.0) 1(100)
no 0 0 1(100) 1(100) 3(50.0) 0
fifth
yes 0 0 0 1(100) 3(100) 1(100)





yes 0 2(100) 0 4(66.7) 1(100) 1(33.3)
no 0 0 1(100) 2(33.3) 0 2(66.7)
second
yes 0 0 0 1(100) 0 0
no 0 0 0 0 2(100) 2(100)
third
yes 0 0 0 0 2(100) 1(50.0)
no 0 0 0 0 0 1(5.00)
fourth
yes 0 0 0 0 0 1(100.0)




yes 1(100) 0 0 2(100) 2(100) 1(100)
no 0 0 0 0 0 0
VF = ventricular fibrillation, VT = ventricular tachycardia
Figure 2. the energy levels for the success and failure of each 
attempt of defibrillation during first episode of VF/VT
DOI: https://doi.org/10.30564/jim.v10i2.3459
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Figure 3. the energy levels for the success and failure of 
defibrillation in first and recurrent VF/ VT
The anti-arrhythmic agents were required in 63.5% 
of the total patients who developed shockable rhythms. 
These were usually administered during multiple attempts 
of defibrillation, or for recurrent VT/VF. Lidocaine 
(43%) was most frequently used, and the least (25%) 
was amiodarone. Lidocaine combined with magnesium, 
amiodarone combined with magnesium, and amiodarone 
combined with lidocaine were given in 15.2, 6.1, and 
3.0%, respectively: triple medications were administered 
in 16.7%. Lidocaine was commonly used in the dose range 
of 50-120 milligrams, with the dose range of magnesium 
being 1-2 grams, and amiodarone was administered in the 
dose of 150-300 milligrams.
During CPB, the patients received inotropic/vasopressor 
agents, which consisted mainly of epinephrine (68.3%). 
The CPB and aortic cross-clamp time were 146.2 ±58.6 
and 105.8 ±46 minutes, respectively. Both of these were not 
significantly different between the successful group and the 
failed group. During CPB, the higher serum bicarbonate (22.4 
& 21.7, p-value =0.009), lower serum calcium (1.08 ± 0.06 
& 1.11 ± 0.07, p-value = 0.02), and lower total cardioplegic 
volume (2250 & 3050, p-value = 0.006) significantly 
increased with the success of the first attempt at defibrillation 
(Table 3). 
Table 3. The cardiopulmonary bypass data of patients who received first attempt of internal defibrillation for their first 
VF/VT.
Perioperative factors







( n = 64)
Fail
(n = 40)
p-value OR (95% CI) p-value
Cardiopulmonary bypass time (mins), median 
±IQR
146.2 ±58.6* 132 (106.2,166.2) 145.5 (113.2,182.5) 0.58
 - -
Aortic cross clamp time (mins), mean ±SD 105.8 ±46 103.4 ± 42.8 109.6 ± 51.2 0.51
- -
Intraoperative inotropic drug, n (%) 103 (99.0) 63 (98.4) 40 (100.0) 1.00 - -
   - Epinephrine 71 (68.3) 42 (65.6) 29 (72.5) 0.61 - -
   - Norepinephrine 46 (44.2) 27 (42.2) 19 (47.5) 0.74 - -
   - Dopamine 18 (17.3) 11 (17.2) 7 (17.5) 1.00 - -
   - Dobutamine 29 (27.9) 18 (28.1) 11 (27.5) 1.00 - -
   - Milrinone 16 (15.4) 7 (10.9) 9 (22.5) 0.19 - -
Body temperature, n (%)
   Nasopharyngeal, median ±IQR 36.9 ±1.1* 37.2 (36.7,37.4) 37.3 (36.8,37.6) 0.11 - -
   Rectal, median ±IQR 35.8 ±1.3* 36 (35.1,36.4) 36.2 (35.6,36.8) 0.17 - -
Mean arterial pressure (mmHg), median ±IQR 52.2 ±13* 50.5 (44,62) 50.5 (40,56) 0.12 - -
ABG, median ±IQR
   -  pH 7.4 ±0.1* 7.4 (7.4,7.4) 7.4 (7.3,7.4) 0.04 - -
   -  PaO2 267.8 ±81.2* 270.5 (83.7) 263.4 (77.9) 0.67 - -
   - PaCO2 37 ±3.9* 36.9 (4.1) 37.1 (3.5) 0.85 - -
   - HCO3
- 22 ±2.2* 22.4 (21.2,23.7) 21.7 (20.4,22.6) 0.01 1.2(1.0-1.5) 0.03
Electrolytes, median ±IQR
   - Sodium 135.8 ±5.3* 135.1 (4.9) 136.8 (5.8) 0.13 - -
   - Potassium 4.4 ±0.6* 4.4 (0.6) 4.3 (0.5) 0.25 - -
   - Chloride 106.3 ±4.3* 107 (104,109) 107 (103.8,110.2) 0.42 - -
   - Calcium 1.1 ±0.1* 1.1 (0.1) 1.1 (0.1) 0.02 0.0003(0-0.3) 0.02




Time from last cardioplegia to VF/VT (mins), 
median ±IQR
45.2 ±44.1* 25.5 (17.8,77.8) 24 (15.5,53.5) 0.563 - -
*= mean ±S.D., ABG= arterial blood gas
DOI: https://doi.org/10.30564/jim.v10i2.3459
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4. Discussion
The energy levels of the internal defibrillation for VF/
VT, occurring during the weaning CPB, in this study 
varied from 5, 7, 10, 20, and 30 J; with a success rate of 
50, 61.5, 64.9, 55.6, and 66.7%, respectively, for the first 
attempt of defibrillation. The success rates of our study 
showed nonlinear correlation with the level of energy 
used for defibrillations. Kerber et al, administered 5, 10, 
and 20 J of shocks, and reported the successes at 56% 
of 5 J shocks, 70% of 10 J shocks, and 80% of 20 J of 
shocks [5]. Carol et al, used 5, 7.5, 10, 20, 30 J shocks, 
and demonstrated that the success rates were 56% of 5 
J, 59% of 7.5 J, 64% of 10 J, 85% of 20 J, and 100% of 
30 J of shocks [4]. Although, our success rate at the high 
energy level of 20 J and 30 J were lower than in the 
previous study [2]; the study by Carol et al, showed that 
an energy level above 2.5 J had a plateau defibrillation 
success rate of 50-60% [4], similar to our results. Schuder 
et al. also reported a nonlinear correlation for transthoracic 
defibrillation shock with success [6]. An increasing level 
of the shock strength, above an optimal range, can 
decrease the success of defibrillation. Several studies have 
demonstrated that an increase in post-shock arrhythmias 
can be a possible cause of unsuccessful defibrillation 
[1,2]. High energy shocks might produce contractile 
abnormalities as well as post-shock arrhythmias, caused 
by ultrastructural damage in the mitochondria of the 
myocardium [2]. This might explain our lower success 
rates at 20 and 30 J shocks in the first attempt. 
A sub-analysis of the success rate at 20 J, from a 
total of 27 shocks, which was not better than the lower 
energy, showed that it was mostly used in valvular surgery 
(59.3%). However, most of the failed shocks occurred in 
CABG, and combined valve with CABG surgery (66.7%). 
A possible etiology for the redevelopment of VF/VT 
would be a coronary air embolism, which is more likely 
during open-heart surgery than coronary artery or close 
heart surgery. Additionally, the presence of coronary artery 
disease also decreases the VF threshold; especially when 
a rapid heart rate is associated with coronary occlusion [2].
The incidences of failure of the fourth or fifth 
defibrillations in redo-valvular surgery, combined CABG 
with valve surgery, adult CHD, and valvular surgery 
were greater than in the patients with CABG, thoracic 
aortic surgery, and other surgeries. Especially, in redo-
valvular and adult CHD surgeries, which were less likely 
to succeed from defibrillation. Carol et al, reported the 
difficulty to defibrillate patients with valvular heart disease 
as well [4]. Incidence of failure to defibrillate patients 
with valvular heart disease with the second or third shock 
was greater than in patients with coronary artery disease. 
The favorable effect of valve surgery on left ventricular 
loading conditions might reduce proarrhythmic stress and 
stretch as well as being associated with proarrhythmic 
risk. Coronary artery disease, structural heart disease, 
and left ventricular dysfunction were among the factors 
that predisposed malignant ventricular arrhythmia. Also, 
cardiac surgery exposes the patients with a substrate for 
ventricular arrhythmia to various arrhythmic triggers; such 
as, ischemia, reperfusion injury, hemodynamic changes, 
and electrolyte shifts that could lead to ventricular 
arrhythmia; especially acute ischemia or reperfusion 
injury [7].
Chapman et al, demonstrated that left ventricular 
hypertrophy (LVH) was significantly correlated with 
the defibrillation threshold [8]. However, Kerber et al, 
found that the LVH did not elevate defibrillation energy 
requirements [9]. From our results, the success rates 
insignificantly correlated with the LVH of the patients. 
However, ejection fraction (EF) can predict the success of 
the shock in the first attempt. This was lower in patients 
with failed shock (48.1%) than in the successful shock 
group (56.9%) (p-value = 0.011). So, higher EF was 
significantly associated with higher successful shocks in 
the first attempt.
Defibrillation during the states of acid-base imbalance 
has been influenced by the effect of derangements on 
the ventricular fibrillation threshold. In an animal study, 
acid-base abnormalities did not elevate defibrillation 
energy requirements; whereas, hypoxia reduced the 
energy needed to defibrillate [9]. Therefore, pH and blood 
gas alterations did not significantly affect the normal 
defibrillation threshold [10]. Higher bicarbonate levels 
significantly increased the success rate in the first attempt 
of shock in our clinical trial, but this different value was 
very scarce in the clinical setting. 
Electrolytes, such as serum potassium, play an 
important role in the evoked potential generation for 
cardiac conduction. From the previous study, the success 
of defibrillation was associated with high serum potassium 
and coronary perfusion pressure at the first shock, and 
could correctly predict the outcome in 78% of the first 
shock [2]. Similar to our results, serum potassium and 
mean arterial pressure in successful shocks were higher 
than in the failed shocks, in the first attempt; but they 
were not significantly different.
VF or VT occasionally persists, and defibrillation 
needed to be repeated. In this case, the conventional 
strategy is to administer l idocaine,  magnesium, 
and various anti-arrhythmic agents, and then repeat 
defibrillation. However, multiple repeated defibrillations 
DOI: https://doi.org/10.30564/jim.v10i2.3459
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not only increase the risk of myocardial damage and 
reduce cardiac function, but may also attenuate the 
fibrillation threshold [11]. Lidocaine and magnesium are 
generally the common drugs of choice in many hospitals; 
this includes our institute. 
There are some limitations in this study. First of all, 
it is a retrospective design. No uniform protocol of the 
energy level and antiarrhythmic drugs is applied for 
internal defibrillation within our hospital. Secondly, the 
blood gas determinations in the majority of the patients 
were not obtained at the exact time of developing VF/VT. 
Instead, they were before the occurrence of VF/VT, and 
after the therapy (defibrillation) in many cases. Finally, 
the numbers of patients for each energy level were too 
small; especially at 5, 7, and 30 J levels, when compared 
with the level at 10 and 20 J. Future prospective studies of 
internal defibrillation may resolve these uncertainties.
5. Conclusions
The success rate of internal defibrillation did not 
significantly correlate to the dose of energy at the levels 
from 7 to 30 J after weaning off cardiopulmonary bypass. 
However, it was significantly related to the preoperative 
ejection fraction, and relatedly converted to intraoperative 
acidosis, serum calcium, and cardioplegic volume.
References
[1] Fotuhi PC. Energy levels for defibrillation: what is of real 
clinical importance? Am J Cardio 1999;83:24D-33D.
[2] Lake CL. Energy dose and other variables possibly 
affecting ventricular defibrillation during cardiac sur-
gery. Anesth Analg 1984;63:743-51.
[3] Tacker WA. The electrical dose for direct ventricu-
lar defibrillation in man. J Thorac Cardiovasc Surg 
1978;75:224-6.
[4] Carol LL. Low-energy defibrillation: Safe and effec-
tive. Am J Emerg Med 1985;3:104-7.
[5] Kerber RE. Open chest defibrillation during cardiac 
surgery. Energy and current requirements. Am J Cardi-
ol 1980;46:393-6.
[6] Schuder JC. Transthoracic ventricular defibrillation 
with triangular and trapezoidal waveforms. Circ Res 
1966;19:689-94. 
[7] David S. Frankel. Ventricular Arrhythmias After Car-
diac Surgery. J Am Coll Cardiol 2012;60;2672-3. 
[8] Chapman PD. Relationship of left ventricular mass to 
defibrillation threshold for the implantable defibrilla-
tor: a combined clinical and animal study. Am Heart J 
1987;114:274-78.
[9] Kerber RE. Effect of ischemia, hypertrophy, hypoxia, 
acidosis, and alkalosis on canine defibrillation. Am J 
Physiol Heart Circ Physiol 2004;286:6.
[10] Yakaitis RW, Thomas JD, Mahaffey JE. Influence of 
pH and hypoxia on the success of defibrillation. Crit 
Care Med 1975;3:139-42.
[11] Shigemitsu O. Analysis of perioperative ventricular 
arrhythmias in valvular heart diseases by Holter ECG 
recording. Jpn Circ J 1991;55:951-61.
DOI: https://doi.org/10.30564/jim.v10i2.3459
